YORBA LINDA, Calif. (PRWEB) August 27, 2018 -- Cardiovascular disease due to atherosclerosis is the leading cause of disease and mortality worldwide. So-called “vulnerable” atherosclerotic plaques are those that are likely to result in clinical events. One of the hallmarks of vulnerable plaques is increased endothelial permeability, a feature that is related to the progression of the disease across all stages of the atherosclerotic cascade.
Increased endothelial permeability at the beginning of atherosclerosis is believed to allow lipid deposition and plaque formation to occur. At later stages it is associated with plaque inflammation and extravasation of inflammatory cells that occurs as a plaque progresses and may eventually lead to plaque rupture.
This webinar, which is sponsored by Bruker, will describe the application of magnetic resonance imaging (MRI) for the characterization of increased endothelial permeability in mouse atherosclerotic plaques using the preclinical Bruker Biospec 7 Tesla horizontal 70/30 scanner and self-gating features (IntraGate). Attendees will learn the advantages of using self-gated techniques for cardiac and vascular imaging, as well as understand the flexibility these techniques provide for individuals working in pre-clinical imaging.
The speakers for this event will be Dr. Claudia Calcagno Mani, an assistant professor in the department of radiology, at Icahn School of Medicine at Mount Sinai New York. Calcagno holds a medical degree from the University of Genova and a doctorate from the Icahn School of Medicine at Mount Sinai/New York University. Her main research interest is dynamic contrast enhanced (DCE) magnetic resonance imaging (MRI) of the atherosclerotic arterial vessel wall.
LabRoots will host the September 20, 2018. Attendees will have two opportunities to watch live, the first session will begin at 10 a.m. CEST and a second will follow at 5 p.m. CEST. To learn more about these webinars, discover the continuing education credits available, or register for free, click here for the first session and here for the second session.
About Bruker Corporation (NASDAQ: BRKR)
For more than 55 years, Bruker has enabled scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and clinical microbiology. For more information, please visit: http://www.bruker.com.
About LabRoots
LabRoots is the leading scientific social networking website, which provides daily scientific trending news and science-themed apparel, as well as produces educational virtual events and webinars, on the latest discoveries and advancements in science. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning, and is a primary source for current scientific news, webinars, virtual conferences, and more. LabRoots has grown into the world’s largest series of virtual events within the Life Sciences and Clinical Diagnostics community.
Karen Sorenson, LabRoots, Inc., http://www.LabRoots.com, +1 (619) 861-0590, [email protected]
Share this article